Correction to: Oncogene
10.1038/s41388-018-0554-z, published online 23 October 2018
Following publication of this article it was noted that Supplementary Tables 1–5 were omitted.
These have now been added to the HTML version of the Article.
. 2019 May 30;38(28):5746. doi: 10.1038/s41388-019-0835-1
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner
1, Georgios Vlachogiannis
2, Alexis De Haven Brandon
1, Melanie Valenti
1, Gary Box
1, Liam Jenkins
3, Caterina Mancusi
1, Annette Self
1, Floriana Manodoro
4, Ioannis Assiotis
4, Penny Robinson
4, Ritika Chauhan
4, Alistair G Rust
4, Nik Matthews
4, Kate Eason
2, Khurum Khan
5, Naureen Starling
5, David Cunningham
5, Anguraj Sadanandam
2, Clare M Isacke
3, Vladimir Kirkin
1, Nicola Valeri
2,5, Steven R Whittaker
1,✉
Steve Wagner
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Steve Wagner
Georgios Vlachogiannis
2Division of Molecular Pathology, The Institute of Cancer Research, London, UK
Find articles by Georgios Vlachogiannis
Alexis De Haven Brandon
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Alexis De Haven Brandon
Melanie Valenti
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Melanie Valenti
Gary Box
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Gary Box
Liam Jenkins
3Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK
Find articles by Liam Jenkins
Caterina Mancusi
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Caterina Mancusi
Annette Self
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Annette Self
Floriana Manodoro
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
Find articles by Floriana Manodoro
Ioannis Assiotis
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
Find articles by Ioannis Assiotis
Penny Robinson
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
Find articles by Penny Robinson
Ritika Chauhan
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
Find articles by Ritika Chauhan
Alistair G Rust
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
Find articles by Alistair G Rust
Nik Matthews
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
Find articles by Nik Matthews
Kate Eason
2Division of Molecular Pathology, The Institute of Cancer Research, London, UK
Find articles by Kate Eason
Khurum Khan
5Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
Find articles by Khurum Khan
Naureen Starling
5Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
Find articles by Naureen Starling
David Cunningham
5Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
Find articles by David Cunningham
Anguraj Sadanandam
2Division of Molecular Pathology, The Institute of Cancer Research, London, UK
Find articles by Anguraj Sadanandam
Clare M Isacke
3Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK
Find articles by Clare M Isacke
Vladimir Kirkin
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Vladimir Kirkin
Nicola Valeri
2Division of Molecular Pathology, The Institute of Cancer Research, London, UK
5Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
Find articles by Nicola Valeri
Steven R Whittaker
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Find articles by Steven R Whittaker
1Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
2Division of Molecular Pathology, The Institute of Cancer Research, London, UK
3Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK
4Tumour Profiling Unit, The Institute of Cancer Research, London, UK
5Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
✉
Corresponding author.
Issue date 2019.
Subject terms: Colorectal cancer, Cancer genomics
© The Author(s), under exclusive licence to Springer Nature Limited 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC7608239 PMID: 31147600
This corrects the article "Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer" on page 1717.